ASSOCIATION OF N-{[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL]METHYL}-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL
Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochlorid...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MULDER, PAULUS ROUSSEL, JÉRÔME VILAINE, JEAN-PAUL FELDMANN, LUC THUILLEZ, CHRISTIAN FRATACCI, MARIE-DOMINIQUE LEREBOURS-PIGEONNIERE, GUY |
description | Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2921168B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2921168B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2921168B13</originalsourceid><addsrcrecordid>eNqNzMFqAjEUBdDZdCG2_5ClQp40k9HRZSYTmUB8L2SyMIqIlHRVWsHuSr-rv9eRFty6ulw4946KH9X3pK2KlpDRmiF87Sd1PwXJK2jtxsSOtqmxOmlH-2pWzp4PpKMCwSWfQwzWINSQ3OFKk_sGCZOaL2_bQZa8uloTg-pSGwhkN7DG4E7tjLc4lOSmgPD3MVTaEgjwgbxCtbFomMKWeRMstuSDdY_Fw-vp7ZKf_nNcsLWJuoN8_jjmy_n0kt_z59H4clUKsVg2Qt5BfgExB0k6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ASSOCIATION OF N-{[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL]METHYL}-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL</title><source>esp@cenet</source><creator>MULDER, PAULUS ; ROUSSEL, JÉRÔME ; VILAINE, JEAN-PAUL ; FELDMANN, LUC ; THUILLEZ, CHRISTIAN ; FRATACCI, MARIE-DOMINIQUE ; LEREBOURS-PIGEONNIERE, GUY</creator><creatorcontrib>MULDER, PAULUS ; ROUSSEL, JÉRÔME ; VILAINE, JEAN-PAUL ; FELDMANN, LUC ; THUILLEZ, CHRISTIAN ; FRATACCI, MARIE-DOMINIQUE ; LEREBOURS-PIGEONNIERE, GUY</creatorcontrib><description>Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160413&DB=EPODOC&CC=EP&NR=2921168B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160413&DB=EPODOC&CC=EP&NR=2921168B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MULDER, PAULUS</creatorcontrib><creatorcontrib>ROUSSEL, JÉRÔME</creatorcontrib><creatorcontrib>VILAINE, JEAN-PAUL</creatorcontrib><creatorcontrib>FELDMANN, LUC</creatorcontrib><creatorcontrib>THUILLEZ, CHRISTIAN</creatorcontrib><creatorcontrib>FRATACCI, MARIE-DOMINIQUE</creatorcontrib><creatorcontrib>LEREBOURS-PIGEONNIERE, GUY</creatorcontrib><title>ASSOCIATION OF N-{[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL]METHYL}-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL</title><description>Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzMFqAjEUBdDZdCG2_5ClQp40k9HRZSYTmUB8L2SyMIqIlHRVWsHuSr-rv9eRFty6ulw4946KH9X3pK2KlpDRmiF87Sd1PwXJK2jtxsSOtqmxOmlH-2pWzp4PpKMCwSWfQwzWINSQ3OFKk_sGCZOaL2_bQZa8uloTg-pSGwhkN7DG4E7tjLc4lOSmgPD3MVTaEgjwgbxCtbFomMKWeRMstuSDdY_Fw-vp7ZKf_nNcsLWJuoN8_jjmy_n0kt_z59H4clUKsVg2Qt5BfgExB0k6</recordid><startdate>20160413</startdate><enddate>20160413</enddate><creator>MULDER, PAULUS</creator><creator>ROUSSEL, JÉRÔME</creator><creator>VILAINE, JEAN-PAUL</creator><creator>FELDMANN, LUC</creator><creator>THUILLEZ, CHRISTIAN</creator><creator>FRATACCI, MARIE-DOMINIQUE</creator><creator>LEREBOURS-PIGEONNIERE, GUY</creator><scope>EVB</scope></search><sort><creationdate>20160413</creationdate><title>ASSOCIATION OF N-{[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL]METHYL}-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL</title><author>MULDER, PAULUS ; ROUSSEL, JÉRÔME ; VILAINE, JEAN-PAUL ; FELDMANN, LUC ; THUILLEZ, CHRISTIAN ; FRATACCI, MARIE-DOMINIQUE ; LEREBOURS-PIGEONNIERE, GUY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2921168B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MULDER, PAULUS</creatorcontrib><creatorcontrib>ROUSSEL, JÉRÔME</creatorcontrib><creatorcontrib>VILAINE, JEAN-PAUL</creatorcontrib><creatorcontrib>FELDMANN, LUC</creatorcontrib><creatorcontrib>THUILLEZ, CHRISTIAN</creatorcontrib><creatorcontrib>FRATACCI, MARIE-DOMINIQUE</creatorcontrib><creatorcontrib>LEREBOURS-PIGEONNIERE, GUY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MULDER, PAULUS</au><au>ROUSSEL, JÉRÔME</au><au>VILAINE, JEAN-PAUL</au><au>FELDMANN, LUC</au><au>THUILLEZ, CHRISTIAN</au><au>FRATACCI, MARIE-DOMINIQUE</au><au>LEREBOURS-PIGEONNIERE, GUY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ASSOCIATION OF N-{[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL]METHYL}-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL</title><date>2016-04-13</date><risdate>2016</risdate><abstract>Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP2921168B1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | ASSOCIATION OF N-{[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7-YL]METHYL}-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A32%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MULDER,%20PAULUS&rft.date=2016-04-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2921168B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |